Researchers are exploring drugs like Ozempic, Mounjaro, and Wegovy to treat or prevent a range of conditions, including ...

According to new, independent research published in the Journal of the American Heart Association, GLP-1 receptor agonist ...

Stroke is a leading cause of death and disability worldwide, with staggering statistics that demand urgent attention. Every year, approximately 12.2 million new strokes are diagnosed globally, and one ...

GLP-1 receptor agonists (GLP-1 RA) medications were shown to reduce the number of deaths, amputations and hospitalizations ...

After one year, people taking a GLP-1 drug had better outcomes than those taking an SGLT-2 drug. Specifically, they were 36% less likely to die from any cause, 12% less likely to be hospitalized, 22% ...

Following the success of obesity treatments, global pharmaceutical and biotech industries are increasingly focusing on the ...

Two of the hottest trends in health — longevity medicine and weight loss drugs — are colliding. A theory that GLP-1 ...

An Australian-first study by the Registry of Senior Australians (ROSA) investigating the use of blood sugar-lowering medications among residents with diabetes in aged care homes nationwide, has ...

The National Institute for Health and Care Excellence (Nice) has approved teplizumab, which the charity Diabetes UK said ...

Credit: Getty Images Our easy-to-read fact sheets provide patients with an overview for type 2 diabetes medications that also induce weight loss. Our easy-to-read fact sheets provide clinicians with ...

Doctors warn that prolonged exposure to heat can damage GLP medications and put those who take GLP medications at risk for ...

If you have type 2 diabetes, it’s important to manage your hormone levels, as an imbalance can alter how your body responds to insulin. Lifestyle measures like reducing stressors and eating a balanced ...